- Home
- HAFN vs LMAT Comparison
HAFN vs LMAT Comparison
Compare HAFN & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAFN
- LMAT
- Stock Information
- Founded
- HAFN 2012
- LMAT 1983
- Country
- HAFN Singapore
- LMAT United States
- Employees
- HAFN N/A
- LMAT N/A
- Industry
- HAFN
- LMAT Medical/Dental Instruments
- Sector
- HAFN
- LMAT Health Care
- Exchange
- HAFN Nasdaq
- LMAT Nasdaq
- Market Cap
- HAFN 2.1B
- LMAT 1.8B
- IPO Year
- HAFN N/A
- LMAT 2006
- Fundamental
- Price
- HAFN $4.25
- LMAT $86.28
- Analyst Decision
- HAFN Strong Buy
- LMAT Buy
- Analyst Count
- HAFN 2
- LMAT 8
- Target Price
- HAFN $8.25
- LMAT $97.00
- AVG Volume (30 Days)
- HAFN 2.0M
- LMAT 244.7K
- Earning Date
- HAFN 05-27-2025
- LMAT 05-01-2025
- Dividend Yield
- HAFN 27.24%
- LMAT 0.93%
- EPS Growth
- HAFN N/A
- LMAT 44.03
- EPS
- HAFN 1.50
- LMAT 1.93
- Revenue
- HAFN $2,868,647,000.00
- LMAT $219,863,000.00
- Revenue This Year
- HAFN N/A
- LMAT $11.00
- Revenue Next Year
- HAFN N/A
- LMAT $8.48
- P/E Ratio
- HAFN $2.62
- LMAT $44.70
- Revenue Growth
- HAFN 7.37
- LMAT 13.63
- 52 Week Low
- HAFN $3.61
- LMAT $62.39
- 52 Week High
- HAFN $8.99
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- HAFN N/A
- LMAT 53.60
- Support Level
- HAFN N/A
- LMAT $82.22
- Resistance Level
- HAFN N/A
- LMAT $87.46
- Average True Range (ATR)
- HAFN 0.00
- LMAT 4.74
- MACD
- HAFN 0.00
- LMAT 0.81
- Stochastic Oscillator
- HAFN 0.00
- LMAT 92.64
About HAFN Hafnia Limited Common Shares
Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.